GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MCL1, MMP2, MMP9, MPO, PIK3CA, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
13.6551 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MCL1, MMP2, MPO, PIK3CA, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TYR |
12.9026 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.7124 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, MPO, PIK3CA, PPARA, PTGS2, RORC, SLC6A4, SRC, TEK, TYR |
11.9829 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.8966 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FUT7, GLO1, HSPA1A, IDO1, MPO, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
11.8433 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR6, INSR, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
11.6462 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR6, INSR, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
11.6222 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP2, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
11.2196 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
11.1476 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
10.3284 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MCL1, MET, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
10.2646 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MCL1, MET, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
10.2017 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CES1, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MCL1, MMP12, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR |
10.0525 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPR35, HCAR2, HSPA1A, HTR6, IDO1, IGF1R, INSR, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
10.0226 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MCL1, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
9.65279 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.52187 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, INSR, KCNH2, KDR, MCL1, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.42917 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IDO1, IGF1R, KDR, MCL1, MET, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
9.39927 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IDO1, IGF1R, KDR, MCL1, MET, MMP9, MPO, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
9.36716 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, EGFR, F10, FLT3, GPR35, HSPA1A, HTR6, INSR, KDR, MCL1, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
9.18154 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CES1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, INSR, KDR, MCL1, MET, MMP2, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPRS, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR |
8.89045 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F10, FLT3, GPR35, HSPA1A, HTR6, INSR, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.89045 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR6, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.7122 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IDO1, IGF1R, KDR, MCL1, MMP9, MPO, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
8.70096 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR6, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.55296 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HSPA1A, HTR6, IGF1R, INSR, KDR, MCL1, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
8.44411 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR6, IDO1, IGF1R, INSR, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
8.40753 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TERT |
8.40545 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, IDO1, MPO, PTGS2, RORC, SLC6A4, SRC, TYR |
8.38984 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK |
8.38975 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FLT3, PTGS2, RORC, SLC6A4, SRC, TEK, TYR |
8.35463 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, PPARA, PTGS2, SLC6A4, SRC, TEK |
8.21419 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
7.99869 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGS2, SRC, TERT |
7.90359 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, ESRRA, F10, FABP4, FLT3, GPR35, HSPA1A, HTR6, IDO1, INSR, KDR, MCL1, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.90342 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.90342 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, HSD17B2, IDO1, IGF1R, INSR, KCNH2, MCL1, MET, MMP1, MMP12, MMP2, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TYR |
7.85815 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.79545 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
7.74715 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.42479 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
7.31594 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, KCNH2, MCL1, MET, PIK3CA, PIK3CB, SMAD3, SRC, TERT |
7.11303 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, PTPRS, SRC, TEK, XDH |
7.04925 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MCL1, MMP2, MMP9, NUAK1, PIK3CA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TERT, TOP2A |
7.01796 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APEX1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT |
7.01631 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, BCL2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SLC6A4, SMAD3, SRC, TERT, XDH |
6.9302 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, BCL2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SLC6A4, SMAD3, SRC, TERT, XDH |
6.91646 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.87881 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.8592 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, IDO1, MPO, NQO2, PTGS1, PTGS2, TYR, XDH |
6.84836 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IDO1, IGF1R, KCNH2, KDR, MCL1, MET, MMP12, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.81691 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, PIK3CA, PTGS2, RORC, SLC6A4, SMAD3, SRC |
6.69999 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, PTPRS, SRC, TEK, XDH |
6.65295 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGS1, PTGS2 |
6.57824 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HCAR2, HSPA1A, IDO1, IGF1R, KCNH2, KDR, MCL1, MET, MMP12, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.45931 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, BCL2, CYP19A1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
6.41239 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, DRD1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.39677 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA3, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSPA1A, IDO1, MCL1, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A |
6.33758 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PIK3CA, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
6.21518 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
6.21518 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, DRD1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.21518 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
6.21518 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, NQO2, PTGS1, RORC |
6.17207 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPR35, HSPA1A, HTR6, IDO1, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
6.16199 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.1 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.1 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
6.09903 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, EGFR, F10, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
6.09903 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.09903 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, BCL2, DRD1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.0979 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CES1, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SLC6A4, SRC |
6.04698 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, IDO1, PPARA, PTGS1, PTGS2 |
6.00893 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CYP19A1, DRD2, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IDO1, IGF1R, MCL1, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
5.94718 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA3, CA9, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, KCNH2, KDR, PTGS2, SLC6A2, SLC6A4, SRC |
5.94715 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CA3, CYP1B1, EGFR, HSPA1A, MMP9, MPO, PTGS1, PTGS2, SRC |
5.92831 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, HTR6, IDO1, IGF1R, INSR, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
5.92831 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HSPA1A, HTR6, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TERT, XDH |
5.92831 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, BCL2, DRD1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.92831 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
5.86883 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.79248 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.75047 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.72675 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK, TERT |
5.52414 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, EGFR, HSPA1A, IDO1, MPO |
5.50148 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, MCL1, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TYR |
5.47249 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD17B1, HSD17B2 |
5.47249 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2 |
5.43407 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, HSPA1A, MMP2, MPO, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
5.41361 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.37152 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, DRD1, DRD2, EGFR, HCAR2, KDR, PIK3CB, PTGS2, SRC |
5.22431 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, EGFR, GPR35, HCAR2, HSPA1A, INSR, KCNH2, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT |
5.22431 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
5.21648 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
5.15227 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
5.12313 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, KCNH2, MET, PIK3CA, PIK3CB, SMAD3 |
5.12313 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, HCAR2, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT |
4.99435 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.98999 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
4.97151 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC |
4.93174 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, EGFR, ESR1, PPARA, RORC, SLC6A4, SRC, TOP2A |
4.91402 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
4.8962 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, EGFR, ESRRB, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.84489 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
4.84489 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.84489 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK |
4.84481 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.68382 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, APEX1, BCL2, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MCL1, MET, PIK3CA, PIK3CB, PPARA, PTPN1, SMAD3 |
4.66984 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, GPR35, HCAR2, HSPA1A, IDO1, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, PTPRS, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.64814 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
4.59146 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.57984 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.57277 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
4.57277 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
4.56324 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
4.54486 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.52341 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGS2, TERT |
4.49054 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.48574 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, IDO1, MPO, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.47518 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, INSR, PTGS2, SLC6A2, SLC6A4, SMAD3 |
4.44622 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, MMP9, PTGS2, PTPN1, SRC |
4.43397 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, DRD2, GPR35, KCNH2, MMP9, PTGS2 |
4.42971 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SLC6A4, SRC |
4.42415 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, DRD2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TERT, XDH |
4.39922 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.39515 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GLO1, IDO1, MPO, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.38741 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
4.38432 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, EGFR, HCAR2, MCL1, MET, PIK3CA, PPARA, SMAD3 |
4.34781 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
4.30902 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.30743 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, MPO, PIK3CB, SRC, XDH |
4.28049 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, EGFR, ESR1, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2, PTPRS, SMAD3, TEK |
4.22525 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, PTGS2, SLC6A4 |
4.22027 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2 |
4.18171 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.17724 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, DRD2, EGFR, FLT3, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH |
4.16784 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, DRD1, EGFR, PTGS2, SLC6A4, SRC, TEK |
4.16632 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, ESR1, HSPA1A, IGF1R, MCL1, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
4.12077 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.11678 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.11678 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, KCNH2, KDR, PTGS2, SRC |
4.11434 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.11186 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, MCL1, PIK3CA, SRC |
4.06859 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2, SLC6A4 |
4.06859 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PTGS2, RORC, SRC, TEK |
4.02536 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.01881 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, DRD2, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH |
4.01881 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
4.00358 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
3.99285 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.98383 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, EGFR, HCAR2, PIK3CB, PTGS2 |
3.9805 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CBR1, CDC25B, CES1, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MCL1, MET, MMP2, MMP9, PTGS2, PTPRS, RORC, SMAD3, SRC, TEK, TERT, TOP2A |
3.975 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
3.95378 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.84028 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
3.84028 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.83874 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
3.82731 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
3.8245 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.65022 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.6292 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.60734 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.60196 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, MMP2, MMP9, PTGS2, SLC6A4, SRC, TOP2A |
3.59513 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, DRD1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SMAD3, SRC |
3.58322 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.57126 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, TYR |
3.53475 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
3.53475 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.52382 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, MCL1, PIK3CA, SRC |
3.46996 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC |
3.46996 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, AXL, BCL2, CA2, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, IDO1, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, PTPRS, SMAD3, SRC |
3.41674 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.40539 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.40198 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MPO |
3.40198 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, AXL, BCL2, CA2, CYP1B1, DRD2, EGFR, ESRRB, HCAR2, HSPA1A, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
3.39804 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, DRD1, EGFR, PTGS2, SLC6A4, SRC, TEK |
3.36673 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TERT, TOP2A |
3.36047 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, DRD2, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.36047 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC |
3.32798 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.3101 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
3.30232 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, MMP9, PTGS2, PTPN1, SRC, TERT |
3.28793 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GLO1, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.27166 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
3.22499 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
3.18854 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, MPO |
3.17957 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, PTGS2 |
3.17661 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
3.17484 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.16241 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.15296 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, MMP9, PTGS2, PTPN1, SRC |
3.15296 |
[BP] GO:0040008 |
regulation of growth
|
BCL2, CSNK2A1, DRD2, EGFR, ESR2, HSPA1A, INSR, MPO, PIK3CA, PIM1, PTPRS, SLC6A4, SMAD3 |
3.14815 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TEK, TYR |
3.14282 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, EGFR, ESR1, ESR2, FLT3, HSPA1A, INSR, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
3.12626 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AURKB, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
3.1204 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TOP2A |
3.11278 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
3.0925 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, EGFR, PTGS2, SLC6A4 |
3.08921 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, EGFR, PTGS2, SLC6A4 |
3.08921 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
3.08827 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
3.08678 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.06847 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR, MPO |
3.06397 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, GPR35, KCNH2, PIK3CB, SMAD3 |
3.05862 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CYP1B1, DUSP3, IDO1, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
3.05862 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
3.04375 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.02349 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, GPR35, PTGS2 |
3.00886 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH |
2.99317 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, EGFR, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
2.98313 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
2.97681 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
2.97423 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
2.97068 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, DRD2, EGFR, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
2.97068 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
2.97068 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
2.97068 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
2.96963 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.95827 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, EGFR, IGF1R, INSR, KCNH2, KDR, MCL1, MET, NUAK1, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
2.94999 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR6, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.94569 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR |
2.93297 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
2.93297 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
2.92889 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.92289 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, IDO1 |
2.91052 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
2.90259 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.90259 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET, PIK3CA |
2.89226 |
[BP] GO:2001240 |
None
|
BCL2, HSPA1A, MCL1, TERT |
2.88696 |
[BP] GO:1901099 |
None
|
BCL2, HSPA1A, MCL1, TERT |
2.88696 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTGS2, SRC |
2.87734 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, IDO1, PTGS2, SLC6A4, SMAD3, TERT, XDH |
2.87607 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, DRD2, EGFR, ESR1, FLT3, HSPA1A, INSR, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
2.86208 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.8339 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.8296 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, HCAR2, IDO1, MCL1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.8281 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CA2, CA7, DRD1, DRD2, GPR35, KCNH2, MMP9, PTGS2, SLC6A4 |
2.82256 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, KCNH2, PPARA, SLC6A2, SLC6A4 |
2.82177 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.81672 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC, TEK |
2.81088 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
2.80075 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, HCAR2, IDO1, MCL1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.79824 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, DRD1, EGFR, PTGS2, SLC6A4 |
2.79824 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, DRD1, EGFR, PTGS2, SLC6A4 |
2.79824 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2, SLC6A4 |
2.79824 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
2.78279 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.78279 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, CHRM2, DRD2, EGFR, GPR35, HCAR2, KCNH2, PTGS2, SMAD3 |
2.77369 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
2.77056 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
2.76327 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, DRD1, EGFR, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
2.75287 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.74635 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
2.73301 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, MPO, PTGS2, SLC6A4, SRC, TYR |
2.7227 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, MMP9, MPO, PIK3CA, PIK3CB, RORC, SMAD3, SRC |
2.72206 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, PIK3CB, PTPN1, SRC |
2.71861 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, TYR |
2.70375 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
2.67964 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, IDO1, MPO, PTGS1, PTGS2 |
2.67176 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, DRD1, EGFR, PTGS2, SLC6A4 |
2.66868 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.65696 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, DRD1, EGFR, PTGS2, SLC6A4 |
2.65295 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AXL, BCL2, CA1, CA2, CHRM2, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, HTR6, IGF1R, INSR, KCNH2, KDR, MCL1, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
2.64908 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, KCNH2, PIK3CB, SMAD3 |
2.63566 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
2.61729 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.61729 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.61729 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, IDO1, PIK3CB |
2.61621 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.61621 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
DUSP3, EGFR, HSPA1A, IGF1R, MCL1, MET, NUAK1, PTGS2, PTPN1, PTPRS, TERT, XDH |
2.59937 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, GPR35, KCNH2, MMP9 |
2.59343 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC |
2.59325 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.58464 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.58026 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, PPARA, PTPRS, SMAD3, TEK |
2.57507 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.57184 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.56249 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.55027 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.54744 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, HCAR2, IDO1, MCL1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.53812 |
[BP] GO:0016311 |
None
|
ALPL, APEX1, BCL2, CA3, CDC25B, DUSP3, PTPN1, PTPRS |
2.53092 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, CHRM2, DRD2, EGFR, KCNH2, PTGS2 |
2.52143 |
[BP] GO:0007200 |
None
|
ADRA2A, CHRM2, DRD1, DRD2, ESR1 |
2.51435 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TOP2A |
2.51201 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.51201 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.51201 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.51201 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, CDC25B, CYP1A1, DUSP3, INSR, TERT |
2.49853 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
ADRA2A, APEX1, BCL2, ESRRB, HSPA1A, INSR, KDR, MCL1, MET, PIK3CA, PIK3CB, PPARA, PTPN1 |
2.47525 |
[BP] GO:2001239 |
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
BCL2, HSPA1A, MCL1, TERT |
2.45737 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.45737 |
[BP] GO:0050776 |
regulation of immune response
|
ALOX15, BCL2, DRD2, DUSP3, ESR1, HSPA1A, IDO1, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, PTPRS, SMAD3, SRC |
2.45556 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.44002 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, EGFR, HCAR2, MMP12, SLC6A4, SRC |
2.43776 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, PPARA, PTGS1, PTGS2, SMAD3 |
2.43776 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.43776 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.43776 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.43776 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC |
2.43776 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, PTGS2, SRC |
2.42313 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.39862 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, GPR35, KCNH2, MMP9 |
2.38622 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, BCL2, CA2, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, IDO1, INSR, KDR, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.38181 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, DRD2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.37444 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, PTGS2, SRC |
2.35343 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, TOP2A |
2.35343 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.35075 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.34478 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.31648 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, KCNH2 |
2.3127 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, PPARA, RORC, TOP2A |
2.3127 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, MPO, PTGS2, TERT |
2.29519 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.28731 |
[BP] GO:0045926 |
negative regulation of growth
|
BCL2, ESR2, HSPA1A, MPO, PTPRS, SLC6A4, SMAD3 |
2.28645 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.28645 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.28645 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.28645 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, GPR35, KCNH2, MMP9 |
2.28004 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, MPO, PTGS2, SLC6A4, SRC, TYR |
2.27569 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC |
2.27167 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CYP19A1, DRD2, DUSP3, IDO1, MMP12, PTPRS |
2.26978 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.26858 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.26858 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.26858 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.26858 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MCL1, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
2.24598 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.2395 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, IDO1, SLC6A2 |
2.2395 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.2395 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, SRC, TERT |
2.23671 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.23068 |
[BP] GO:0001817 |
regulation of cytokine production
|
ADRA2A, AXL, CYP1B1, DRD2, HSPA1A, IDO1, MMP12, PTGS2, PTPRS, SMAD3, SRC |
2.21808 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.21808 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.21808 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.21808 |
[BP] GO:0007613 |
None
|
DRD1, DRD2, INSR, PTGS2, SLC6A4 |
2.20571 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TOP2A |
2.19713 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.1965 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.1965 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.1965 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AURKB, BCL2, CSNK2A1, DRD2, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
2.19637 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.19544 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.18507 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.17441 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, EGFR, ESR1, GPR35, KCNH2, PIK3CB, SMAD3 |
2.17441 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.17441 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.17441 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.17441 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.17441 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.17441 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.15426 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, AXL, PIK3CA, PIK3CB, SRC |
2.13204 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB |
2.13022 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK |
2.12315 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.12315 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.12315 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MCL1, MMP9, NUAK1, PTGS2, PTPN1, SRC, TERT, TOP2A |
2.10947 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, MMP12, SRC |
2.08933 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.07986 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TERT |
2.07694 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.0745 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.0745 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.07445 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.05431 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2 |
2.04815 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, CHRM2, DRD1, DRD2, HTR6 |
2.03709 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.03709 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, HSPA1A, INSR, KDR, PIK3CB, PPARA, PTPN1 |
2.03133 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, PIK3CB, PTPN1, SRC |
2.01851 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.01554 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.01554 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.01554 |
[BP] GO:0008150 |
biological_process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, HTR6, IDO1, IGF1R, INSR, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
2.00779 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.00716 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KCNH2, KDR, MCL1, MMP2, MMP9, MPO, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SLC6A4, SMAD3, SRC, TERT, TOP2A, TYR, XDH |
3.99239 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F10, FLT3, GLO1, GPR35, HCAR2, HTR6, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, PTPRS, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
3.88993 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CA4, CHRM2, DRD1, DRD2, F10, FLT3, GPR35, HTR6, IGF1R, INSR, KDR, MET, PTPRS, SLC6A2, SLC6A4, TEK |
3.15534 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, ALOX15, AXL, CA2, CA4, CA9, CHRM2, DRD1, DRD2, DUSP3, EGFR, F10, FLT3, GPR35, HTR6, IGF1R, INSR, KCNH2, KDR, MET, PTGS2, PTPRS, SLC6A2, SLC6A4, SRC, TEK |
2.94634 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.78595 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD1, DRD2, FLT3, GPR35, HTR6, IGF1R, INSR, KDR, MET, PTPRS, SLC6A2, SLC6A4, TEK |
2.46809 |
[CC] GO:0045121 |
membrane raft
|
EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
2.45556 |
[CC] GO:0098857 |
membrane microdomain
|
EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
2.43776 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, EGFR, ESR1, F10, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B2, HTR6, IGF1R, INSR, KCNH2, KDR, MCL1, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
2.37444 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MCL1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TERT, TOP2A, TYR, XDH |
2.24545 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, CA2, CA4, CA9, CHRM2, DRD1, DRD2, EGFR, INSR, MET, PTGS2, SRC, TEK |
2.17332 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, HTR6, IDO1, IGF1R, INSR, KDR, MCL1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SMAD3, SRC, TERT, TOP2A, TYR, XDH |
2.15502 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HTR6, IGF1R, INSR, KCNH2, KDR, MCL1, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, PTPRS, SLC6A2, SLC6A4, SRC, TEK, TYR |
2.07843 |
[CC] GO:0098589 |
membrane region
|
EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
2.00198 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
18.5707 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
16.7701 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
14.7189 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, F10, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SRC, TEK, TERT, TOP2A, TYR, XDH |
13.9973 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.8227 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.7708 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
10.3284 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC, SMAD3 |
9.92665 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
8.89045 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
8.83119 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, IDO1, MPO, NQO2, PTGS1, PTGS2, TYR, XDH |
8.33122 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, SLC6A4, SRC, TEK, TOP2A |
7.01195 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, IDO1, MPO, PTGS1, PTGS2, SRC |
6.91708 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.88504 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, IDO1, MPO, PTGS1, PTGS2, SRC |
6.65295 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.14098 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, HTR6, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
5.81782 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, IDO1, MPO, NQO2, PTGS1, PTGS2, SRC, XDH |
5.14656 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
5.04279 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, HTR6, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
4.89963 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
4.85224 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.81895 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.81895 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
4.80778 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, HTR6, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SMAD3, TEK |
4.75906 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, HTR6, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
4.68264 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
4.67684 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.65557 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MCL1, MET, MMP9, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
4.57984 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
4.45309 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.40355 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.22055 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, FLT3, KCNH2, MCL1, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
4.16784 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS1, PTGS2, TYR |
4.16632 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
4.11678 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
3.78978 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.68895 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 |
3.57968 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
3.55409 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TERT |
3.53906 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD17B1, HSD17B2, XDH |
3.52382 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AXL, BCL2, DRD2, EGFR, FLT3, KCNH2, MCL1, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
3.49919 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.46996 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.33785 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.27801 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.27801 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.21551 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.16241 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.81672 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.81672 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.71861 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CA3, CDC25B, CES1, CES2, DUSP3, PTPN1, PTPRS |
2.61669 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD1, DRD2, EGFR, FLT3, GPR35, HCAR2, HTR6, IGF1R, INSR, KDR, MET, TEK |
2.54553 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM2, DRD1, DRD2, EGFR, FLT3, GPR35, HCAR2, HTR6, IGF1R, INSR, KDR, MET, TEK |
2.54553 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.51937 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.45955 |
[MF] GO:0051213 |
dioxygenase activity
|
ALOX15, ALOX5, IDO1, PTGS1, PTGS2 |
2.45737 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.43776 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.43776 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.43776 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, AURKB, AXL, CSNK2A1, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTPRS, SRC, TEK, TOP2A, XDH |
2.36788 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRA2A, AXL, BCL2, DRD2, EGFR, MCL1, SMAD3, TOP2A, TYR |
2.30451 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2 |
2.26858 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.26858 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.24598 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PTPN1, PTPRS, SRC, TEK |
2.21808 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRB, HSPA1A, KCNH2, MET, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TOP2A |
2.21808 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.1965 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.1965 |
[MF] GO:0008227 |
None
|
ADRA2A, CHRM2, DRD2, HTR6 |
2.17441 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.02684 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.01554 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.01554 |
[MF] GO:0051434 |
BH3 domain binding
|
BCL2, MCL1 |
2.01554 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 |
2.00022 |